Govt to expedite process of recognition of Biological E Corbevax by other countries Ruchika Sharma30 April 2022 11:56 AM ISTNew Delhi: The government plans to expedite the process of recognition of COVID-19 vaccine Corbevax by other countries while its manufacturer...
Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6 Ruchika Sharma29 April 2022 11:59 AM ISTModerna is also currently studying booster doses for all pediatric cohorts.
Bharat Biotech must address WHO's Covaxin suspension to avoid emergency use approval cancellation: MEA Ruchika Sharma29 April 2022 10:00 AM ISTThe communication stated that a proper response or policy from the government needs to be formulated on the issue and on further pursuance of...
Pfizer seeks USFDA emergency use nod for COVID booster in children aged 5 through 11 years Ruchika Sharma28 April 2022 3:22 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (USFDA) for Emergency Use Authorization...
DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children Dr. Nandita Mohan27 April 2022 5:43 PM ISTThe Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for...
Health Bulletin 27/April/2022 Dr. Nandita Mohan27 April 2022 4:58 PM ISTHere are the top health stories for the day :NMC denies permission to 3 Medical Colleges, 550 MBBS seats lostFinding major deficiencies in three major...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
Use 10 cr Covishield doses offered free of cost by GAVI: SII urges Centre Ruchika Sharma25 April 2022 11:00 AM ISTThe cumulative COVID-19 vaccine doses administered in the country has so far exceeded 187.67 crore.
GSK- CureVac experimental COVID variant vaccine effective in mice study Ruchika Sharma24 April 2022 9:15 AM ISTFrankfurt: CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly...
DCGI panel asks Bharat Biotech to provide additional data on Covaxin for 2-12 years old Ruchika Sharma23 April 2022 2:49 PM ISTNo recommendations have been made as of now, sources told ANI.
Serum Institute CEO warns against return to business-as-usual approach Ruchika Sharma23 April 2022 10:30 AM IST"The momentum of the past that brought us so far here is lost. As you said it seems for them, it's business as usual," Poonawalla said.
Early trial of Novavax COVID-Influenza vaccine shows promise Ruchika Sharma23 April 2022 10:00 AM ISTThe safety and tolerability profile of the combination vaccine was consistent with the stand-alone NVX-CoV2373 and quadrivalent nanoparticle influenza...
